CD34 and neoplasm: When mice with subcutaneously transplanted TEB and engrafted with human CD34+ HSCs were 11 weeks later injected orthotopically with human MDA-MB-231BO metastatic TNBC cells, formation of primary tumor and metastases to hTEB was observed.